| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ATRS | ANTARES PHARMA, INC. | Richardson Peter C | See Remarks | May 24, 2022 | Option Exercise | $5.60 | 50,613 | 283,433 | 0 | May 26, 2022, 05:27 PM | |
| ATRS | ANTARES PHARMA, INC. | Richardson Peter C | EVP, R&D Chief Medical Officer | Jun 10, 2021 | Option Exercise | $4.42 | 36,199 | 160,000 | 36,199 | Jun 14, 2021, 06:25 PM | |
| MNKD | MANNKIND CORP | Richardson Peter C | Chief Scientific Officer | Mar 03, 2012 | Option Exercise | $2.28 | 3,143 | 7,166 | 133,611 | Mar 06, 2012, 05:00 PM | |
| MNKD | MANNKIND CORP | Richardson Peter C | Chief Scientific Officer | Aug 15, 2011 | Option Exercise | $2.79 | 1,091 | 3,044 | 139,063 | Aug 19, 2011, 07:30 PM | |
| MNKD | MANNKIND CORP | Richardson Peter C | Chief Scientific Officer | Aug 19, 2011 | Option Exercise | $2.41 | 2,309 | 5,565 | 137,972 | Aug 19, 2011, 07:30 PM | |
| MNKD | MANNKIND CORP | Richardson Peter C | Chief Scientific Officer | Aug 19, 2010 | Option Exercise | $5.97 | 1,091 | 6,513 | 111,254 | Aug 23, 2010, 07:02 PM | |
| MNKD | MANNKIND CORP | Richardson Peter C | Chief Scientific Officer | Aug 16, 2010 | Option Exercise | $6.53 | 319 | 2,083 | 112,345 | Aug 17, 2010, 03:57 PM | |
| MNKD | MANNKIND CORP | Richardson Peter C | Chief Scientific Officer | Aug 15, 2010 | Option Exercise | $6.53 | 1,091 | 7,124 | 112,664 | Aug 17, 2010, 03:57 PM | |
| MNKD | MANNKIND CORP | Richardson Peter C | Chief Scientific Officer | Aug 01, 2010 | Option Exercise | $6.91 | 4,135 | 28,573 | 113,755 | Aug 03, 2010, 05:02 PM |
Menu